tci Medicare Compliance & Reimbursement - 2004 Issue 9
Pharmaceuticals: Watch For Tighter Medicaid Rebate Enforcement
AWP could shrink to AMOP after government pricing investigation.Drugmakers, you saw this one coming. Medicaid drug pricing is taking a seat at the top of the congressional "to-do" list.The Committee on Energy and Commerce is launching an "extensive investigation" into pharmaceutical reimbursement under Medicaid, and that means drug companies can expect to see states become more aggressive about collecting Medicaid rebates.In a letter to the General Accounting Office Feb. 4, Subcommittee on Oversight & Investigations Chairman James Greenwood (R-PA) says he wants the watchdog agency to set its sights on controlling Medicaid drug costs which have...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Thank you for choosing Find-A-Code, please Sign In to remove ads.